Category: CovidienSyndicate content

Medtronic-Covidien merger will rival JNJ medical device operations | The week in medtech M&A

June 25, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Seven questions raised by Medtronic's $43B Covidien acquisition; Medtronic, Covidien merger: Good or bad for medtech innovation?; Medtronic, Covidien merger: Mass. Gov. Deval Patrick says he's had no contact with either company; Volcano closes $117M AtheroMed buy; Incubator group buys prostate treatment tech from Endo Health.

Seven questions raised by Medtronic's $43B Covidien acquisition

June 18, 2014 by Brad Perriello

Five take-aways from the Medtronic-Covidien deal

Medtronic taps strategy exec to lead Covidien integration | Personnel Moves

June 25, 2014 by Brad Perriello

Medtronic names Geoff Martha, its senior vice president for strategy & business development, as chief integration officer as it preps to digest the $43 billion Covidien acquisition.

Medtronic taps strategy exec to lead Covidien integration | Personnel Moves

Covidien's next-gen Pipeline embolization lands in Europe

June 24, 2014 by Arezu Sarvestani

Covidien launches its Pipeline Flex embolization system in European markets after landing CE Mark earlier this year.

Covidien's Pipeline embolization lands in Europe

Medtech giant Covidien (NYSE:COV) announced this week that it's prepared to launch its Pipeline Flex embolization devices in Europe.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien levels another lawsuit at Ethicon Endo over ultrasound shears

June 24, 2014 by Brad Perriello

Covidien files another patent infringement lawsuit against Johnson & Johnson's Ethicon Endo-Surgery division over ultrasound shears technology.

Covidien levels another lawsuit at Ethicon Endo over ultrasound shears

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Does the Medtronic-Covidien mega-merger leave startups in the cold? | MassDevice.com On Call

June 24, 2014 by Arezu Sarvestani

Medtech giants Medtronic and Covidien aren't likely to be very acquisitive after finalizing their $43 billion merger, taking 2 very important players out of the game for startup companies, venture capitalists say.

MassDevice.com On Call

Medtronic acquires Covidien in a $43 billion deal | Medtech Wall Street news for the week of June 16, 2014

June 19, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Blockbuster: Medtronic in $43B deal to acquire Covidien; Medtronic buyout holds $80M in golden parachutes for Covidien execs; FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device; European Commission tables review of Zimmer's $13B acquisition of Biomet; Ackman takes Allergan to court to defend against poison pill

Blockbuster: Medtronic in $43B deal to acquire Covidien

June 16, 2014 by Brad Perriello

Blockbuster: Medtronic in $43B deal to acquire Covidien
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp